Skip to main content
Menu
US

HTRF Human Granzyme B Detection Kit, 10,000 Assay Points

HTRF Human Granzyme B Detection Kit is designed for the rapid detection of human Granzyme B in cell supernatant and whole cells.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Sample Volume 16 µL

HTRF Human Granzyme B Detection Kit is designed for the rapid detection of human Granzyme B in cell supernatant and whole cells.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 500 Assay Points
Part #:
62HGRZBPEG
List Price
USD 896.90
Unit Size: 10,000 Assay Points
Part #:
62HGRZBPEH
List Price
USD 11,120.00

Overview

Granzyme B (also called Cathepsin G-like 1, Cytotoxic T-lymphocyte proteinase 2, Fragmentin-2, Granzyme-2, or Human lymphocyte protein) is found in cytotoxic lymphocytes, NK (natural killer) cells, and cytotoxic T cells. Secreted with Perforin, which creates a pore in the cell membrane, it enters the target cell's cytoplasm and triggers apoptosis through caspase activation.

This kit is designed for the rapid detection of human Granzyme B in cell supernatant and whole cells. The assay enables high throughput without any washing steps, thereby saving time compared to ELISA.

Specifications

Application
Protein Quantification
Brand
HTRF
Detection Modality
HTRF
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Biomarkers
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Oncology & Inflammation
Unit Size
10,000 Assay Points

Video gallery

How it works

Assay principle

Human Granzyme B is a sandwich immunoassay involving two specific anti-human Granzyme B antibodies, respectively labelled with Europium Cryptate (donor) and d2 (acceptor). The intensity of the signal is proportional to the concentration of Granzyme B present in the sample.

biomarkers-how-it-works-assay-principle-granzyme-b-62hgrzbpeg-62hgrzbpeh.svg
Assay Protocol

The assay protocol, using a 384-well small volume white plate or a Revvity low volume 96-well plate (20 µL final), is described on the right. 16 µL of cell supernatant, sample, or standard are dispensed directly into the plate for detection by HTRF reagents. The antibodies labelled with HTRF donor and acceptor can be pre-mixed and added in a single dispensing step to further streamline the assay procedure. The assay can be run in 96- to 384-well plates by simply resizing each addition volume proportionally.

biomarkers-how-it-works-assay-protocol-granzyme-b-62hgrzbpeg-62hgrzbpeh.svg

 

Assay details

Technical specifications of the Granzyme B kit
Sample size 16 µL
Final assay volume 20 µL
Kit components lyophilized standard, frozen detection antibodies, buffers & protocol
LOD & LOQ (in diluent)  1.8 ng/mL & 3.7 ng/mL
Range 3.7 – 1,500 ng/mL
Time to result  ON at RT

 

Analytical performance

Granzyme B standard curve

Recombinant Granzyme B provided in the kit (standard) was serially diluted in diluent #5, following the procedure given in the kit’s package insert. The HTRF signal, expressed as a delta ratio, was plotted as a function of the Granzyme B concentrations.

analytical-performance-human-granzyme-b-1.svg
Precision

intra assay (n=24)

Sample Mean [GranzymeB] (pg/mL) CV
1 644 14%
2 438 14%
3 23 18%
  Mean CV 15%


Each of the 3 samples was measured 24 times, and % CV was calculated for each sample. 
 

Inter assay (n=4)

Sample [GranzymeB]
(pg/mL)
Mean
(deltaRatio)
CV
1 10 576 9%
2 54 2759 6%
3 652 18940 6%
    Mean CV 7%


Each of the samples was measured in 4 different experiments, and % CV was calculated for each sample. 
 

Assay validation

Detection of Granzyme B on cell supernatant (one-plate protocol)

Different cell densities (4K and 2K) of TALL-104 cells (Effector cells) were co-cultured with or without K-562 cells (Target cells) in suspension under 16µL in 384-well sv microplates. The cells were incubated for 16 hours at 37°C - 5% CO2. After co-culture, 4 µL of the HTRF Granzyme B detection reagents were added. The HTRF signal was recorded after an overnight incubation at RT.

assay-validation-human-granzyme-b-1.svg
Detection of Granzyme B on cell supernatant (Two-plate protocol)

Different cell densities (50K and 25K) of TALL-104 cells (Effector cells) were plated in suspension under 50µL in 96-well plates. TALL-104 cells were co-cultured with or without K-562 cells (Target cells) for 16 hours at 37°C - 5% CO2. After co-culture, 16µL of cell supernatants were transferred into a 384-well sv white microplate and 4 µL of the HTRF Granzyme B detection reagents were added. The HTRF signal was recorded after an overnight incubation at RT.

assay-validation-human-granzyme-b-2.svg

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Flyer Icon
Flyer
Reagent solutions for autoimmunity research.

Advance your autoimmune disease research and benefit from Revvity broad offering of reagent technologies

Scroll Icon